Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.6, 2014-06, pp. : 681-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Albumin-Bound Paclitaxel: In Metastatic Breast Cancer

By Robinson Dean M. Keating Gillian M.

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 941-948

Adis International

Access to resources Recommend Favorite

Albumin-bound paclitaxel: a next-generation taxane

By Gradishar William J

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1041-1053

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy evaluation of albumin-bound paclitaxel

By Cecco Sara Aliberti Maria Baldo Paolo Giacomin Elisa Leone Roberto

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Albumin-bound paclitaxel cost effective in MBC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

By Guarneri Valentina Dieci Maria Vittoria Conte PierFranco

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 395-406

Informa Healthcare

Access to resources Recommend Favorite